Lung Cancer Clinical Trials

Showing 21-40 of 2,032 trials

Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block

NCT06618599

This study aims to compare efficacy of Mid-transverse process to pleura block combined with erector spinae block versus paravertebral plane block in cancer patients undergoing thoracotomy surgeries.

Lung Cancer

Cairo University60 participantsStarted Oct 2024

Cairo, Egypt

RECRUITINGPHASE1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775

First in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with other anti-cancer agents in patients with advanced solid tumors.

Solid Tumor, AdultMetastatic Breast CancerAdvanced Breast Cancer+8 more

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)392 participantsStarted Oct 2024

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +29 more locations

Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Related Searches

Insights on Dissemination of Lung Cancer

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Empathic Communication Skills (ECS) Training

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

Health Education Approach to Lung Screening

A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

SYS6090 Combination Therapy in Advanced Lung Cancer

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers

Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)